Transcript
Page 1: Meningococcal septicaemia

Canterbury Health Laboratories

Meningococcal septicaemia

Rachel C Hutton, PhDMedical Laboratory Scientist

Page 2: Meningococcal septicaemia

Canterbury Health Laboratories

Diagnosis Meningococcus

• Disease• Transmissio

n• Symptoms• Diagnosis• Treatment• Prevention

• Case Study

Page 3: Meningococcal septicaemia

Canterbury Health LaboratoriesMeningococcal Disease

• Contagious bacterial disease

• Neisseria meningitidis– Fastidious aerobe– Gram Negative Diplococci (GNDC)– 12 serogroups

• 6 can cause epidemic (A, B, C, W135, X, Y) (WHO)

• Humans only natural carriers

• Meningitis• Meningococcemia• Pneumonia• Arthritis• Urethritis

Page 4: Meningococcal septicaemia

Canterbury Health LaboratoriesTransmission

– Exchange of respiratory/throat secretions

– Cough/sneeze

– Close contact – household members

– 10% population are carriers (nose/throat)

– Carriers are crucial to disease transmission

Page 5: Meningococcal septicaemia

Canterbury Health LaboratoriesSymptoms

• Meningitis– Nausea– Vomiting– Photophobia– Altered mental status

• Meningococcemia– Fatigue– Vomiting– Cold hands and feet– Cold chills– Severe aches or pain– Rapid breathing– Diarrhoea– Petechial rash (dark purple)

Source: CDC online

Page 6: Meningococcal septicaemia

Canterbury Health LaboratoriesDisease

• 5-10% of patients die within 24-48H

• Meningitidis– Brain damage– Hearing loss– Learning disability

• Septicaemia– Haemorrhagic rash– Rapid circulatory collapse

Page 7: Meningococcal septicaemia

Canterbury Health LaboratoriesDiagnosis

• Clinical Examination

• Gram Stain

• Culture

• Agglutination

• PCR

• MALDI-TOF

– Susceptibility testing– Serogroups

Page 8: Meningococcal septicaemia

Canterbury Health LaboratoriesTreatment & Prevention

• Medical Emergency

• Antibiotics immediately ( after LP/Blood)– Penicillin– Ampicillin– Chloramphenicol– Ceftriaxone

• Vaccination– Polysaccharide

• Bivalent (A&C), Trivalent (A,C,W), Tetravalent (A,C,Y,W135)– Outer Membrane Protein (OML)

– Group B– Conjugate Vaccines

• Tetravalent (A,C,Y,W135)

Page 9: Meningococcal septicaemia

Canterbury Health Laboratories

CASE STUDY:MENINGOCOCCAL DISEASE

Case Study: Meningococcal disease

Page 10: Meningococcal septicaemia

Canterbury Health Laboratories

Case Study:Meningococcal disease

Day

Event Tests/Results Treatment

0 Presents to GP Diagnosed as EBVNo bloods

None – sent home

Page 11: Meningococcal septicaemia

Canterbury Health Laboratories

Day

Event Tests/Results Treatment

0 Presents to GP Diagnosed as EBVNo bloods

None – sent home

1 Found by mother

Unresponsive Ambulance called

Ambulance GCS 8/15 (E2V2M4)Skin cool & mottledRash (Non-blanching erythematous confluent)HR 76BP not palpableAirway patient – sat not recorded (NR)

IV ceftriaxone

Page 12: Meningococcal septicaemia

Canterbury Health Laboratories

Day Event Tests/Results Treatment

1 ED GCS 9/15CT head Scan = No pathological changes

IV DexamethasoneIV fluidsAdrenalin

ICU LP not performed due to coagulopathyLow BPBlood tests-INR 3.1-No evidence of DIC-Raised blood glucose

IV VancomycinIV Acyclovar2 u FFPNoradrenalin

Insulin infusion

Serology EBV IgG PositiveEBV IgM NegativeEBV EBNA Positive

Evidence of PAST infection with EBV

Microbiology Blood Cultures = Negative-Blood, Arterial, CVC

IV Acyclovar StoppedIV Dexamethasone Stopped

Page 13: Meningococcal septicaemia

Canterbury Health Laboratories

Day Event Tests/Results Treatment

1 ED GCS 9/15CT head Scan = No pathological changes

IV DexamethasoneIV fluidsAdrenalin

ICU LP not performed due to coagulopathyLow BPBlood tests-INR 3.1-No evidence of DIC-Raised blood glucose

IV VancomycinIV Acyclovar2 u FFPNoradrenalin

Insulin infusion

Serology EBV IgG PositiveEBV IgM NegativeEBV EBNA Positive

Evidence of PAST infection with EBV

Primary diagnosis = meningococcal meningitis

Blood Cultures = Negative-Blood, Arterial, CVCEDTA – N. meningitidis PCR = Positive

IV Acyclovar StoppedIV Dexamethasone Stopped

Page 14: Meningococcal septicaemia

Canterbury Health Laboratories

Day Event Tests/Results Treatment

2 Extubated Continued improvementMild headache & photophobia

3 Transferred to Ward

Ceftriaxone 2g Q12HTEDS

7 Discharged

Page 15: Meningococcal septicaemia

Canterbury Health Laboratories

This is not the end of the story…

Page 16: Meningococcal septicaemia

Canterbury Health LaboratoriesDiagnosis Arthritis

Day Event Tests/Results Treatments

9 Increasing unwellPainful knee + elbowLines present L hand + R groin

Admitted to orthopaedic ward

CRP 102WCC elevatedPyreticR Knee = swollen, effusion, good ROMGroin = visible scab from line, no erythema, tender, able to weight bare

Wash out elbow + knee (under GA)IV ceftriaxoneIV flucloxacillin

12 Washout L elbow CRP 32Full ROM Hip & KneeLimitation at extremes of left elbow extension

R hip joint aspirated & washed out

N. meningitidis DNA detected

18 Discharged

Page 17: Meningococcal septicaemia

Canterbury Health LaboratoriesBlood Tests: Trends

WBCNeutrophils

Platelets

INR Fibrinogen

Page 18: Meningococcal septicaemia

Canterbury Health Laboratories

CRP

pH Blood Base Excess

Page 19: Meningococcal septicaemia

Canterbury Health Laboratories

EDTA N. meningitidis DNA detected

Page 20: Meningococcal septicaemia

Canterbury Health Laboratories

Samples Sent to Microbiology

Day Sample Results

9 L Elbow Aspirate BC bottle NG

9 L Elbow Aspirate PottleAnti co-ag tube

NOSWBC 175600 x106/L– predom polynucleated

RBC 12700 x106

No CrystalsNG

9 R Knee Aspirate BC bottle GPCNG

9 R Knee Aspirate PottleAnti co-ag tube

Occasional GPCWBC 5950 x106/L– predom polynucleated

RBC 1520 x106/LNo CrystalsNG16S rRNA PCR: Bacterial DNA not detected

10 R Knee Aspirate Syringe NOSScanty leucocytesNG

12 Hip Aspirate PottleAnti co-ag tube

NOSWBC 51650 x106/L – predom polynuecleatedRBC 2800 x106/L

N. meningitidis PCR = Detected

Page 21: Meningococcal septicaemia

Canterbury Health LaboratoriesThe Value of PCR

Day Sample Results

9 L Elbow Aspirate BC bottle NG

9 L Elbow Aspirate PottleAnti co-ag tube

NOSWBC 175600 x106/L– predom polynucleated

RBC 12700 x106

No CrystalsNG

9 R Knee Aspirate BC bottle GPCNG

9 R Knee Aspirate PottleAnti co-ag tube

Occasional GPCWBC 5950 x106/L– predom polynucleated

RBC 1520 x106/LNo CrystalsNG16S rRNA PCR: Bacterial DNA not detected

10 R Knee Aspirate Syringe NOSScanty leucocytesNG

12 Hip Aspirate PottleAnti co-ag tube

NOSWBC 51650 x106/L – predom polynuecleatedRBC 2800 x106/L

N. meningitidis PCR = Detected

Page 22: Meningococcal septicaemia

Canterbury Health LaboratoriesRequest Forms

Page 23: Meningococcal septicaemia

Canterbury Health Laboratories

Page 24: Meningococcal septicaemia

Canterbury Health Laboratories

The Value of PCR

Day 12: Hip Aspirate

Test Add N. meningitidis PCR

Result = Positive

Page 25: Meningococcal septicaemia

Canterbury Health LaboratoriesMeningococcal Burdon

Page 26: Meningococcal septicaemia

Canterbury Health LaboratoriesMeningococcal Burden

• Meningococcal disease causes life-threatening meningitis and sepsis conditions

• Patient's health can change from good to mortally ill within hours

• As the antibiotics kill the bacteria, they release more toxin. It can take several days for the toxin to be neutralized from the body

• Despite antibiotic therapy ~ 1/10 will die

• ~ 1/10 survivors will lose a limb, loose their hearing or suffer permanent brain damage

Page 27: Meningococcal septicaemia

Canterbury Health LaboratoriesThank you

• Dr Sophie Wen• Jen Fahey• Elaine Keith• CHL


Top Related